They include regulation of ESR1 expression by epigenetic factors[9], mutations of ESR1[10], alternative splicing events[11], alterations in the hormone-binding domain[10], differential recruitment of coregulators[12], factors of the tumor microenvironment[13] and many others [14,15]. This evidence concerns the gene ESR1 and neoplasm.